Yu B - Search Results

1

The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study.

Li J, Li J, Zhong M, Zhou H, Yu B. Li J, et al. Among authors: yu b. Cancer Manag Res. 2021 Feb 16;13:1541-1549. doi: 10.2147/CMAR.S292293. eCollection 2021. Cancer Manag Res. 2021. PMID: 33623433 Free PMC article.

2

Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B-cell lymphoma.

Tian T, Li J, Xue T, Yu B, Li X, Zhou X. Tian T, et al. Among authors: yu b. Cancer Med. 2020 Apr;9(7):2330-2342. doi: 10.1002/cam4.2870. Epub 2020 Feb 5. Cancer Med. 2020. PMID: 32022486 Free PMC article.

3

Clinical significance of circulating exosomal PD-L1 and soluble PD-L1 in extranodal NK/T-cell lymphoma, nasal-type.

Li JW, Wei P, Guo Y, Shi D, Yu BH, Su YF, Li XQ, Zhou XY. Li JW, et al. Am J Cancer Res. 2020 Dec 1;10(12):4498-4512. eCollection 2020. Am J Cancer Res. 2020. PMID: 33415014 Free PMC article.

4

Universal extracellular vesicles and PD-L1+ extracellular vesicles detected by single molecule array technology as circulating biomarkers for diffuse large B cell lymphoma.

Li JW, Shi D, Wan XC, Hu J, Su YF, Zeng YP, Hu ZJ, Yu BH, Zhang QL, Wei P, Zhou XY. Li JW, et al. Oncoimmunology. 2021 Oct 29;10(1):1995166. doi: 10.1080/2162402X.2021.1995166. eCollection 2021. Oncoimmunology. 2021. PMID: 34745768 Free PMC article.

5

Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions.

Su Y, Yao Q, Xu Y, Yu C, Zhang J, Wang Q, Li J, Shi D, Yu B, Zeng Y, Zhu X, Bai Q, Zhou X. Su Y, et al. Among authors: yu b, yu c. Front Genet. 2021 Nov 30;12:674094. doi: 10.3389/fgene.2021.674094. eCollection 2021. Front Genet. 2021. PMID: 34917121 Free PMC article.

6

SMYD3 promotes aerobic glycolysis in diffuse large B-cell lymphoma via H3K4me3-mediated PKM2 transcription.

Tian T, Li J, Shi D, Zeng Y, Yu B, Li X, Wei P, Zhou X. Tian T, et al. Among authors: yu b. Cell Death Dis. 2022 Sep 3;13(9):763. doi: 10.1038/s41419-022-05208-7. Cell Death Dis. 2022. PMID: 36057625 Free PMC article.

7

Clinicopathologic features and abnormal signaling pathways in plasmablastic lymphoma: a multicenter study in China.

Shi D, Gao L, Wan XC, Li J, Tian T, Hu J, Zhang QL, Su YF, Zeng YP, Hu ZJ, Yu BH, Li XQ, Wei P, Li JW, Zhou XY. Shi D, et al. BMC Med. 2022 Dec 15;20(1):483. doi: 10.1186/s12916-022-02683-9. BMC Med. 2022. PMID: 36522654 Free PMC article.

8

IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B-cell lymphoma.

Jiang XN, Yu F, Xue T, Xia QX, Bai QM, Yu BH, Shui RH, Zhou XY, Zhu XZ, Cao JN, Hong XN, Li XQ. Jiang XN, et al. Cancer Med. 2023 May;12(9):10684-10693. doi: 10.1002/cam4.5828. Epub 2023 Apr 20. Cancer Med. 2023. PMID: 37081786 Free PMC article.

9

Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma.

Xue T, Lin JX, He YQ, Li JW, Liu ZB, Jia YJ, Zhou XY, Li XQ, Yu BH. Xue T, et al. Heliyon. 2024 Jan 12;10(2):e24376. doi: 10.1016/j.heliyon.2024.e24376. eCollection 2024 Jan 30. Heliyon. 2024. PMID: 38312674 Free PMC article.

10

FOXP1 expression and its clinicopathologic significance in nodal and extranodal diffuse large B-cell lymphoma.

Yu B, Zhou X, Li B, Xiao X, Yan S, Shi D. Yu B, et al. Ann Hematol. 2011 Jun;90(6):701-8. doi: 10.1007/s00277-010-1124-9. Epub 2010 Dec 1. Ann Hematol. 2011. PMID: 21120478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,516 results

Search Page

Filters